|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alamgeer M, Peacock CD, Matsui W, Ganju V
and Watkins DN: Cancer stem cells in lung cancer: Evidence and
controversies. Respirology. 18:757–764. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kelsey CR, Marks LB, Hollis D, Hubbs JL,
Ready NE, D'amico TA and Boyd JA: Local recurrence after surgery
for early stage lung cancer. Cancer. 115:5218–5227. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Murray N, Coy P, Pater JL, Hodson I,
Arnold A, Zee B, Payne D, Kostashuk EC, Evans WK and Dixon P:
Importance of timing for thoracic irradiation in the combined
modality treatment of limited-stage small-cell lung cancer. The
national cancer institute of Canada clinical trials group. J Clin
Oncol. 11:336–344. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wisnivesky JP, Yankelevitz D and Henschke
CI: Stage of lung cancer in relation to its size: Part 2. Evidence.
Chest. 127:1136–1139. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Devesa SS, Bray F, Vizcaino AP and Parkin
DM: International lung cancer trends by histologic type:
Male:female differences diminishing and adenocarcinoma rates
rising. Int J Cancer. 117:294–299. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Donnenberg VS and Donnenberg AD: Multiple
drug resistance in cancer revisited: The cancer stem cell
hypothesis. J Clin Pharmacol. 45:872–877. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lapidot T, Sirard C, Vormoor J, Murdoch B,
Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and
Dick JE: A cell initiating human acute myeloid leukaemia after
transplantation into SCID mice. Nature. 367:645–648. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
13
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bertolini G, Roz L, Perego P, Tortoreto M,
Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S,
et al: Highly tumorigenic lung cancer CD133+ cells
display stem-like features and are spared by cisplatin treatment.
Proc Natl Acad Sci USA. 106:16281–16286. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Leung EL, Fiscus RR, Tung JW, Tin VP,
Cheng LC, Sihoe AD, Fink LM, Ma Y and Wong MP: Non-small cell lung
cancer cells expressing CD44 are enriched for stem cell-like
properties. PLoS One. 5:e140622010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qiu X, Wang Z, Li Y, Miao Y, Ren Y and
Luan Y: Characterization of sphere-forming cells with stem-like
properties from the small cell lung cancer cell line H446. Cancer
Lett. 323:161–170. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang F, Qiu Q, Khanna A, Todd NW, Deepak
J, Xing L, Wang H, Liu Z, Su Y, Stass SA and Katz RL: Aldehyde
dehydrogenase 1 is a tumor stem cell-associated marker in lung
cancer. Mol Cancer Res. 7:330–338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang X, Yang Y, Tang S, Tang H, Yang G, Xu
Q and Wu J: Anti-tumor effect of polysaccharides from
Scutellaria barbata D. Don on the 95-D xenograft model via
inhibition of the C-met pathway. J Pharmacol Sci. 125:255–263.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yue H, Huang D, Qin L, Zheng Z, Hua L,
Wang G, Huang J and Huang H: Targeting lung cancer stem cells with
antipsychological drug thioridazine. Biomed Res Int 2016.
67098282016.
|
|
21
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: Models and concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Watanabe TK, Katagiri T, Suzuki M, Shimizu
F, Fujiwara T, Kanemoto N, Nakamura Y, Hirai Y, Maekawa H and
Takahashi Ei: Cloning and characterization of two novel human cDNAs
(NELL1 and NELL2) encoding proteins with six EGF-like repeats.
Genomics. 38:273–276. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang X, Kuroda S, Carpenter D, Nishimura
I, Soo C, Moats R, Iida K, Wisner E, Hu FY, Miao S, et al:
Craniosynostosis in transgenic mice overexpressing Nell-1. J Clin
Invest. 110:861–870. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aghaloo T, Cowan CM, Chou YF, Zhang X, Lee
H, Miao S, Hong N, Kuroda S, Wu B, Ting K and Soo C: Nell-1-induced
bone regeneration in calvarial defects. Am J Pathol. 169:903–915.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang X, Carpenter D, Bokui N, Soo C, Miao
S, Truong T, WU B, Chen I, Vastardis H, Tanizawa K, et al:
Overexpression of Nell-1, a craniosynostosis-associated gene,
induces apoptosis in osteoblasts during craniofacial development. J
Bone Miner Res. 18:2126–2134. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakamura R, Oyama T, Tajiri R, Mizokami A,
Namiki M, Nakamoto M and Ooi A: Expression and regulatory effects
on cancer cell behavior of NELL1 and NELL2 in human renal cell
carcinoma. Cancer Sci. 106:656–664. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jin Z, Mori Y, Yang J, Sato F, Ito T,
Cheng Y, Paun B, Hamilton JP, Kan T, Olaru A, et al:
Hypermethylation of the nel-like 1 gene is a common and early event
and is associated with poor prognosis in early-stage esophageal
adenocarcinoma. Oncogene. 26:6332–6340. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maeda K, Matsuhashi S, Tabuchi K, Watanabe
T, Katagiri T, Oyasu M, Saito N and Kuroda S: Brain specific human
genes, NELL1 and NELL2, are predominantly expressed in
neuroblastoma and other embryonal neuroepithelial tumors. Neurol
Med Chir (Tokyo). 41:582–589. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shohet JM, Ghosh R, Coarfa C, Ludwig A,
Benham AL, Chen Z, Patterson DM, Barbieri E, Mestdagh P, Sikorski
DN, et al: A genome-wide search for promoters that respond to
increased MYCN reveals both new oncogenic and tumor suppressor
microRNAs associated with aggressive neuroblastoma. Cancer Res.
71:3841–3851. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ting K, Vastardis H, Mulliken JB, Soo C,
Tieu A, Do H, Kwong E, Bertolami CN, Kawamoto H, Kuroda S and
Longaker MT: Human NELL-1 expressed in unilateral coronal
synostosis. J Bone Miner Res. 14:80–89. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cochrane CR, Szczepny A, Watkins DN and
Cain JE: Hedgehog signaling in the maintenance of cancer stem
cells. Cancers (Basel). 7:1554–1585. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
de Sousa e Melo F and Vermeulen L: Wnt
signaling in cancer stem cell biology. Cancers (Basel). 8:E602016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu X, Lu Y, Li Y and Prinz RA: Sonic
hedgehog signaling in thyroid cancer. Front Endocrinol (Lausanne).
8:2842017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Behrens J, von Kries JP, Kühl M, Bruhn L,
Wedlich D, Grosschedl R and Birchmeier W: Functional interaction of
β-catenin with the transcription factor LEF-1. Nature. 382:638–642.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun J, Zhang C, Liu G, Liu H, Zhou C, Lu
Y, Zhou C, Yuan L and Li X: A novel mouse CD133 binding-peptide
screened by phage display inhibits cancer cell motility in vitro.
Clin Exp Metastasis. 29:185–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Firtina Karagonlar Z, Koç D, Şahin E, Avci
ST, Yilmaz M, Atabey N and Erdal E: Effect of adipocyte-secreted
factors on EpCAM+/CD133+ hepatic stem cell population. Biochem
Biophys Res Commun. 474:482–490. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Suman S, Das TP and Damodaran C: Silencing
NOTCH signaling causes growth arrest in both breast cancer stem
cells and breast cancer cells. Br J Cancer. 109:2587–2596. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Eyler CE and Rich JN: Survival of the
fittest: Cancer stem cells in therapeutic resistance and
angiogenesis. J Clin Oncol. 26:2839–2845. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang J, Liao J, Zhang F, Song D, Lu M, Liu
J, Wei Q, Tang S, Liu H, Fan J, et al: NEL-like molecule-1 (Nell1)
is regulated by bone morphogenetic protein 9 (BMP9) and potentiates
BMP9-induced osteogenic differentiation at the expense of
adipogenesis in mesenchymal stem cells. Cell Physiol Biochem.
41:484–500. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ding D, Lou X, Hua D, Yu W, Li L, Wang J,
Gao F, Zhao N, Ren G, Li L and Lin B: Recurrent targeted genes of
hepatitis B virus in the liver cancer genomes identified by a
next-generation sequencing-based approach. PLoS Genet.
8:e10030652012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jiang X, Xu M, Yin D, Zhang Z, Yu J, Black
K and Liu G: Expression and functional analysis of Nell-1 on cancer
stem cells and glioma patients' survival. Am Association Cancer
Res. 68:12–16. 2008.
|
|
44
|
Slovak ML, Bedell V, Hsu YH, Estrine DB,
Nowak NJ, Delioukina ML, Weiss LM, Smith DD and Forman SJ:
Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease
onset reveal distinct copy number alterations in chemosensitive
versus refractory Hodgkin lymphoma. Clin Cancer Res. 17:3443–3454.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gao C and Zhang Q, Kong D, Wu D, Su C,
Tong J, Chen F and Zhang Q: MALDI-TOF mass array analysis of Nell-1
promoter methylation patterns in human gastric cancer. Biomed Res
Int 2015. 1369412015.
|
|
46
|
Mori Y, Cai K, Cheng Y, Wang S, Paun B,
Hamilton JP, Jin Z, Sato F, Berki AT, Kan T, et al: A genome-wide
search identifies epigenetic silencing of somatostatin,
tachykinin-1, and 5 other genes in colon cancer. Gastroenterology.
131:797–808. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kuroda S, Oyasu M, Kawakami M, Kanayama N,
Tanizawa K, Saito N, Abe T, Matsuhashi S and Ting K: Biochemical
characterization and expression analysis of neural
thrombospondin-1-like proteins NELL1 and NELL2. Biochem Biophys Res
Commun. 265:79–86. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bokui N, Otani T, Igarashi K, Kaku J, Oda
M, Nagaoka T, Seno M, Tatematsu K, Okajima T, Matsuzaki T, et al:
Involvement of MAPK signaling molecules and Runx2 in the
NELL1-induced osteoblastic differentiation. FEBS Lett. 582:365–371.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cowan CM, Jiang X, Hsu T, Soo C, Zhang B,
Wang JZ, Kuroda S, Wu B, Zhang Z, Zhang X and Ting K: Synergistic
effects of Nell-1 and BMP-2 on the osteogenic differentiation of
myoblasts. J Bone Miner Res. 22:918–930. 2007. View Article : Google Scholar : PubMed/NCBI
|
